| Caitlyn Gomez, | |
|
4401 S Claiborne Ave, New Orleans, LA 70125-5105 | |
| (504) 891-7737 | |
| Not Available |
| Full Name | Caitlyn Gomez |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 4401 S Claiborne Ave, New Orleans, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043086473 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PST.025093 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Caitlyn Gomez, 8012 Willow St, New Orleans, LA 70118-4060 Ph: (504) 913-5190 | Caitlyn Gomez, 4401 S Claiborne Ave, New Orleans, LA 70125-5105 Ph: (504) 891-7737 |
News Archive
Vaccination against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rolled out in many countries, including the United States. As the number of coronavirus disease (COVID-19) cases continues to rise, vaccinating many people in the population is crucial. Despite campaigns to inform residents of the benefits of vaccines, many are still reluctant to get vaccinated.
GE Healthcare Ltd. and ImaginAb, Inc. have executed a master research agreement around the development of new PET (Positron Emission Tomography) diagnostic imaging agents based on ImaginAb's antibody fragment technology. The agreement is launched with an initial exclusive collaboration around a novel cardiovascular target.
The study investigated the effect of the various interventions in South Africa on the outbreak, analyzing trends in South Africa before and after the national lockdown, which started on March 27, 2020. Africa has so far reported over 38,000 cases, a small number compared to the 3.25 million global cases as of April 30, 2020. South Africa has reported over 5,600, with Egypt and Morocco close behind.
Novartis announced today new pivotal Phase III data showing 45% of children with active systemic juvenile idiopathic arthritis (SJIA) were able to substantially reduce their use of oral corticosteroids (often described as steroids) within 28 weeks of commencing treatment with ACZ885.
› Verified 7 days ago
Dr. Shauntel Parker Khan, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5610 Read Blvd Ste 113, New Orleans, LA 70127 Phone: 504-241-8188 Fax: 504-264-5941 | |
Courtney N Harrell, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3100 Gentilly Blvd., New Orleans, LA 70122 Phone: 504-940-1480 | |
Julie Storc Relan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3621 General Degaulle Dr, New Orleans, LA 70114 Phone: 504-362-0700 Fax: 504-362-3315 | |
Thai-tue Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4110 General Degaulle Dr, New Orleans, LA 70131 Phone: 504-433-3297 | |
Dr. Keturah Reid Robinson, PHARM.D, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Drexel Dr, New Orleans, LA 70125 Phone: 504-520-5049 | |
Melissa Kelley, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5300 Tchoupitoulas St, New Orleans, LA 70115 Phone: 504-899-0034 Fax: 504-899-2613 | |
Dr. Brittany Marie Gorden, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Drexel Dr, New Orleans, LA 70125 Phone: 504-520-5350 |